These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 5463597)
21. Viral oncogenicity and viral vaccines--general comments. Gerber P Natl Cancer Inst Monogr; 1968 Dec; 29():447-8. PubMed ID: 4888932 [No Abstract] [Full Text] [Related]
22. Tissue and medium antigens in vaccines--discussion. Feldman HA Natl Cancer Inst Monogr; 1968 Dec; 29():193-4. PubMed ID: 5720791 [No Abstract] [Full Text] [Related]
23. [Cell-containing substrates and vaccine production]. Majer M Schweiz Med Wochenschr; 1970 Nov; 100(48):2086-9. PubMed ID: 5003834 [No Abstract] [Full Text] [Related]
24. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments. Fellowes ON Natl Cancer Inst Monogr; 1968 Dec; 29():209-14. PubMed ID: 5720794 [No Abstract] [Full Text] [Related]
25. Development of a cell line system susceptible to infection with vaccine strains of MDV. Abujoub AA; Williams DL; Reilly JD Acta Virol; 1999; 43(2-3):186-91. PubMed ID: 10696443 [TBL] [Abstract][Full Text] [Related]
26. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments. Jensen KE Natl Cancer Inst Monogr; 1968 Dec; 29():207-8. PubMed ID: 5720793 [No Abstract] [Full Text] [Related]
27. Studies with an attenuated canine distemper vaccine derived from chick embryo cultures. Prydie J Res Vet Sci; 1968 Sep; 9(5):443-52. PubMed ID: 5693317 [No Abstract] [Full Text] [Related]
28. Veterinary vaccines. LaSalle B Natl Cancer Inst Monogr; 1968 Dec; 29():515-22. PubMed ID: 4305439 [No Abstract] [Full Text] [Related]
29. Vaccines produced in heteroploid cell lines--discussion. Hull RN Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366 [No Abstract] [Full Text] [Related]
30. Production and evaluation of a formalin-killed Chikungunya vaccine. Harrison VR; Eckels KH; Bartelloni PJ; Hampton C J Immunol; 1971 Sep; 107(3):643-7. PubMed ID: 4999088 [No Abstract] [Full Text] [Related]
34. Characteristics of cell culture systems: viral flora of tissue sources and tissue and medium antigens in vaccines--summary. Sigel MM; von Magnus H Natl Cancer Inst Monogr; 1968 Dec; 29():551-4. PubMed ID: 4976867 [No Abstract] [Full Text] [Related]
35. Blood group antigens in virus vaccines. Franks D; Dawson A Natl Cancer Inst Monogr; 1968 Dec; 29():195-9. PubMed ID: 4888928 [No Abstract] [Full Text] [Related]
36. Suggested criteria for the acceptability of a passaged diploid cell population as substrate for virus vaccine production. Perkins FT Jpn J Med Sci Biol; 1971 Oct; 24(5):336-41. PubMed ID: 5003825 [No Abstract] [Full Text] [Related]
37. TGE of swine. I. Propagation of virus in cell cultures and development of a vaccine. Welter CJ Vet Med Small Anim Clin; 1965 Oct; 60(10):1054-8. PubMed ID: 5173811 [No Abstract] [Full Text] [Related]
38. Cell culture as a substrate for the production of influenza vaccines: memorandum from a WHO meeting. Bull World Health Organ; 1995; 73(4):431-5. PubMed ID: 7554013 [TBL] [Abstract][Full Text] [Related]
39. Cells, vaccines, and the pursuit of precedent. Hilleman MR Natl Cancer Inst Monogr; 1968 Dec; 29():463-9. PubMed ID: 4888933 [No Abstract] [Full Text] [Related]
40. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties. Foley GE Natl Cancer Inst Monogr; 1968 Dec; 29():217-28. PubMed ID: 4888929 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]